ESTÉTICA
GAMA DE PRODUTOS – COMPOSIÇÃO
| Indicações | GLODERM 20 | GLODERM 30 |
|---|---|---|
| Concentração de HA (mg ml) | 20 | 30 |
| Nível de reticulação | 0 | 0 |
| Viscosidade | Intermediário | Alto |
| Profundidade de injeção sugerida | Derme superficial | Superficial à derme média |
| Capacidade de elevação | – | – |
| Embalagem | 1 x 1 ml | 1 x 1 ml |
| Indicações sugeridas | • Rejuvenescimento global do rosto, pescoço, decote, mãos • H idratação dos lábios | • Rejuvenescimento global do rosto • Melhoria das cicatrizes de acne |
| Tamanho da agulha | 30 G | 30 G |
O QUE OS USUÁRIOS DIZEM
“Gloderm 30L has an amazing performance, stability and durance. Its Elasticity and Viscosity brings out an exquisite balance, with an ideal Tan Delta ratio. It lasts for 14-16 months. It shows amazing improvement of tissues, when building up mid-face area, malar prominence, nose bridge, creating jaw line and reshaping the soft tissue pogonion of the chin. It is truly a revolutionary product as it acts like an implant, but at the same time, can be reversible if needed. The first real liquid implant has been born!”
Dr. Ivona Igerc
HongKong/China
“I have been treating my patients for several years with the preparations Gloderm 20L and 30L. They are easy to handle, safe and give excellent results that last. The response of my patients is excellent, especially in terms of volume build-up and the sustainability of the results. I can recommend the products Gloderm 20 and 30 unrestricted.”
Prof. Dr. med. Nils S. Nowacki
India
“The main reasons why I chose Gloderm are certainly the simplicity of the injection, the absolute absence of collateral effects, the extreme ergonomics of the syringe and the complete manageability (flexibility) of the molecule (of the Hyaluronic acid). Moreover, compared to the other competitors on the market, Gloderm has an excellent ratio between the dose of product used and the result obtained.”
Dr. Vito Marino Posa
Egypt
Categorías
Empresa
Medios
Contáctanos
© Copyright Biotech /Terms Of Use - Privacy Policy
Version 2_CT_1212222